BBVA
CVS icon

Banco Bilbao Vizcaya Argentaria’s CVS Health CVS Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.3M Sell
283,446
-3,522
-1% -$314K 0.18% 91
2026
Q1 		$20.6M Sell
286,968
-11,498
-4% -$886K 0.14% 119
2025
Q4 		$23.7M Sell
298,466
-4,469
-1% -$352K 0.17% 104
2025
Q3 		$22.8M Buy
302,935
+2,595
+0.9% +$178K 0.17% 105
2025
Q2 		$20.7M Sell
300,340
-5,920
-2% -$388K 0.19% 100
2025
Q1 		$20.7M Buy
306,260
+5,941
+2% +$356K 0.21% 96
2024
Q4 		$13.4M Sell
300,319
-31,293
-9% -$1.76M 0.14% 138
2024
Q3 		$20.8M Sell
331,612
-1,313
-0.4% -$76.6K 0.21% 99
2024
Q2 		$19.7M Buy
332,925
+77,711
+30% +$4.86M 0.21% 99
2024
Q1 		$20.4M Buy
255,214
+4,185
+2% +$320K 0.23% 90
2023
Q4 		$19.8M Sell
251,029
-1,992
-0.8% -$142K 0.23% 97
2023
Q3 		$17.7M Sell
253,021
-28,247
-10% -$2M 0.24% 100
2023
Q2 		$19.5M Buy
281,268
+14,877
+6% +$1.06M 0.25% 95
2023
Q1 		$19.8M Buy
266,391
+13,245
+5% +$1.11M 0.25% 94
2022
Q4 		$23.6M Buy
253,146
+6,221
+3% +$600K 0.34% 69
2022
Q3 		$23.6M Buy
246,925
+4,598
+2% +$455K 0.38% 60
2022
Q2 		$22.5M Buy
242,327
+13,489
+6% +$1.32M 0.34% 69
2022
Q1 		$23.1M Buy
228,838
+69,497
+44% +$7.3M 0.31% 74
2021
Q4 		$16.5M Buy
159,341
+47,266
+42% +$4.37M 0.22% 94
2021
Q3 		$9.54M Buy
112,075
+7,172
+7% +$601K 0.15% 124
2021
Q2 		$8.74M Buy
104,903
+14,909
+17% +$1.22M 0.16% 127
2021
Q1 		$6.8M Buy
89,994
+18,189
+25% +$1.32M 0.13% 133
2020
Q4 		$4.9M Sell
71,805
-24,593
-26% -$1.6M 0.11% 167
2020
Q3 		$5.63M Buy
96,398
+23,428
+32% +$1.46M 0.16% 112
2020
Q2 		$4.74M Buy
72,970
+17,572
+32% +$1.11M 0.15% 116
2020
Q1 		$3.29M Buy
55,398
+23,894
+76% +$1.6M 0.12% 171
2019
Q4 		$2.34M Buy
+31,504
New +$2.21M 0.07% 283

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's CVS Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its CVS Health (CVS) stake by 1.2% in Q2 2026, selling an estimated $314K and leaving 283,446 shares worth $29.3M. The position accounts for 0.18% of the portfolio, ranked #91.

Banco Bilbao Vizcaya Argentaria first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 283,446 shares of CVS Health worth $29.3M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria sold 3,522 CVS Health shares in Q2 2026, an estimated $314K.
  • CVS Health made up 0.18% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #91 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.